DAFNA Capital Management LLC - GRITSTONE ONCOLOGY INC ownership

Back to all holdings Add to watchlist

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 57 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q2 2020$332,000
+14.1%
50,0000.0%0.10%
-20.7%
Q1 2020$291,000
-35.2%
50,0000.0%0.12%
-21.4%
Q4 2019$449,000
+3.9%
50,0000.0%0.15%
-4.9%
Q3 2019$432,000
-22.4%
50,0000.0%0.16%
-22.5%
Q2 2019$557,000–50,000–0.21%–
 Download
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders